Copyright © 1990 by the European Society of Cardiology.
© 1990 The European Society of Cardiology
The results of surgery for atrial septal defect in patients
Regional Adult Cardiothoracic Unit, Broadgreen Hospitalx Liverpool, U.K.
Received 23 December 1988; revised 19 May 1989; .
correspondence: Mr B. M. Fabri, MD, FRCS (Ed), Regional Adult Cariothoracic Unit, Broadgreen Hosptial, Thomas Drive, Liverpool L14LB, U.K.
Abstract
We examined the cases of 31 patients over the age of 50 years undergoing operative closure of isolated ostium secundum atrial septal defect. The lesion had been diagnosed in all cases prior to cardiac catheterizaton. To assess the importance of pre-operative data on surgical outcome, the patients were first divided into three groups according to mean pulmonary artery pressure (PAP): < 16 mmHg (Group A), 16–30 mmHg (Group B) and > 30 mmHg (Group C). Symptomatic improvement occurred in all groups but more patients in Group C, although symptomatically improved, remained short of breath and in atrial fibrillation than in Group A. Patients in Group A had a higher actual forced vital capacity expressed as a percentage of the predicted value (FVCa/FVCp) than patients in Group B or Group C (P<0–015). There was a good correlation between FVCa/FVCp and percentage oxygen saturation of the arterial blood (P < 00009). This simple non-invasive investigation was therefore found to correlate with previously documented parameters, pulmonary artery pressure and percentage oxygen saturation of the arterial blood, affecting surgical outcome. Patients were also divided into groups according to FVCa/ FVCp: <75% (Group 1) ,50–75% (Group 2) and < 50% (Group3). Postoperative symptoms were more common in Group 3 than in Group 1. We conclude that respiratory function tests, as well as measurement of pulmonary artery pressures, are useful in predicting improvement following atrial septal repair.
Key Words: Atrial septal defect • pulmonary artery pressure • respiratory function tests
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Yoshida, O. Narumi, M. Chin, K. Inoue, T. Tabuchi, K. Oda, M. Nagayama, N. Egawa, M. Hojo, Y. Goto, et al. Characterization of Carotid Atherosclerosis and Detection of Soft Plaque with Use of Black-Blood MR Imaging AJNR Am. J. Neuroradiol., May 1, 2008; 29(5): 868 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Huang, J. C. Thompson, P. G. Wilson, H. H. Aung, J. C. Rutledge, and L. R. Tannock Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development J. Lipid Res., March 1, 2008; 49(3): 521 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Leosco, G. Rengo, G. Iaccarino, A. Filippelli, A. Lymperopoulos, C. Zincarelli, F. Fortunato, L. Golino, M. Marchese, G. Esposito, et al. Exercise training and beta-blocker treatment ameliorate age-dependent impairment of beta-adrenergic receptor signaling and enhance cardiac responsiveness to adrenergic stimulation Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1596 - H1603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Fach, L.-A. Garulacan, J. Gao, Q. Xiao, S. M. Storm, Y. P. Dubaquie, S. A. Hefta, and G. J. Opiteck In Vitro Biomarker Discovery for Atherosclerosis by Proteomics Mol. Cell. Proteomics, December 1, 2004; 3(12): 1200 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Öörni, M. O. Pentikäinen, M. Ala-Korpela, and P. T. Kovanen Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions J. Lipid Res., November 1, 2000; 41(11): 1703 - 1714. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Corseaux, T. Meurice, I. Six, L. Rugeri, M. D. Ezekowitz, P. Rouvier, R. Bordet, C. Bauters, and B. Jude Basic Fibroblast Growth Factor Increases Tissue Factor Expression in Circulating Monocytes and in Vascular Wall Circulation, April 25, 2000; 101(16): 2000 - 2006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Berger, M. Vogel, A. Kramer, V. Alexi-Meskishvili, Y. Weng, P. E. Lange, and R. Hetzer Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery Ann. Thorac. Surg., July 1, 1999; 68(1): 75 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Paka, Y. Kako, J. C. Obunike, and S. Pillarisetti Apolipoprotein E Containing High Density Lipoprotein Stimulates Endothelial Production of Heparan Sulfate Rich in Biologically Active Heparin-like Domains. A POTENTIAL MECHANISM FOR THE ANTI-ATHEROGENIC ACTIONS OF VASCULAR APOLIPOPROTEIN E J. Biol. Chem., February 19, 1999; 274(8): 4816 - 4823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sartipy, G. Bondjers, and E. Hurt-Camejo Phospholipase A2 Type II Binds to Extracellular Matrix Biglycan : Modulation of Its Activity on LDL by Colocalization in Glycosaminoglycan Matrixes Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1934 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V Andrle, J Hruda, and A Zapletal Pulmonary function in children with atrial septal defect before and after heart surgery Heart, November 1, 1998; 80(5): 484 - 488. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Engelberg State-of the-Art Review : Endogenous Heparin Activity Deficiency and Atherosclerosis Clinical and Applied Thrombosis/Hemostasis, April 1, 1996; 2(2): 83 - 93. [PDF]
|
|